Better care for less money: cost-effectiveness of integrated care in multi-episode patients with severe psychotic disorders.
To compare cost-effectiveness of integrated care with therapeutic assertive community treatment (IC-TACT) versus standard care (SC) in multiple episode psychosis. 12-month IC-TACT in patients with schizophrenia-spectrum and bipolar I disorders were compared with a historical control group. Primary outcomes were entropy-balanced cost-effectiveness based on mental health care costs from a payers' perspective and quality-adjusted life years (QALYs) as a measure of health effects during 12-month follow-up. At baseline, patients in IC-TACT (n=214) had significantly higher illness severity and lower functioning than SC (n=56). Over 12 months, IC-TACT had significantly lower days in inpatient (10.3±20.5 vs. 28.2±44.9; p=0.005) and day-clinic care (2.6±16.7 vs. 16.4±33.7; p=.004) and correspondingly lower costs (€-55,084). Within outpatient care, IC-TACT displayed a higher number of treatment contacts (116.3±45.3 vs. 15.6±6.3) and higher related costs (€+1,417). Both resulted in lower total costs in IC-TACT (mean difference=€-13,248±2,975, p<0.001). Adjusted incremental QALYs were significantly higher for IC-TACT versus SC (+0.10±0.37, p=0.05). The probability of cost-effectiveness of IC-TACT was constantly higher than 99%. IC-TACT was cost-effective compared with SC. The use of prima facies 'costly' TACT teams is highly recommended to improve outcomes and save total cost for patients with severe psychotic disorders.